Module Details

Module Code: BIOT8005
Title: BioPharmaceutical Science
Long Title: Advanced BioPharmaceutical Sci
NFQ Level: Advanced
Valid From: Semester 1 - 2017/18 ( September 2017 )
Duration: 1 Semester
Credits: 5
Field of Study: 4218 - Biotechnology
Module Delivered in: 1 programme(s)
Module Description: A comprehensive overview of the development and clinical applications of key protein, nucleic acid and cell based therapies.
 
Learning Outcomes
On successful completion of this module the learner will be able to:
# Learning Outcome Description
LO1 Critically assess the current status and future prospects of the biopharmaceutical industry.
LO2 Evaluate and describe key protein based therapeutics and immunotherapeutics; their development, production and mode of action.
LO3 Describe the clinical applications of nucleic-acid and whole-cell based therapeutics.
LO4 Critically evaluate the rise of Functional Foods and Pharmabiotics in the context of the Biopharmaceutical industry.
LO5 Critically evaluate the activities of key players in the BioPharmaceutical industry - with a focus on the company, product and targeted disease.
Dependencies
Module Recommendations

This is prior learning (or a practical skill) that is strongly recommended before enrolment in this module. You may enrol in this module if you have not acquired the recommended learning but you will have considerable difficulty in passing (i.e. achieving the learning outcomes of) the module. While the prior learning is expressed as named MTU module(s) it also allows for learning (in another module or modules) which is equivalent to the learning specified in the named module(s).
Incompatible Modules
These are modules which have learning outcomes that are too similar to the learning outcomes of this module. You may not earn additional credit for the same learning and therefore you may not enrol in this module if you have successfully completed any modules in the incompatible list.
No incompatible modules listed
Co-requisite Modules
No Co-requisite modules listed
Requirements

This is prior learning (or a practical skill) that is mandatory before enrolment in this module is allowed. You may not enrol on this module if you have not acquired the learning specified in this section.
No requirements listed
 
Indicative Content
An introduction to Bioharmaceutical Science
A detailed analysis of the key milestones leading to the development of modern BioPharmaceutical Science.
Protein Therapeutics
A comprehensive overview of the key protein based therapeutics and immunotherapeutics currently in development; including Cytokines (IFN, IL, TNF), Therapeutic Hormones (Insulin, Glucagon, Human Growth Hormone, Gonadotrophins), Therapeutic Enzymes (Asparaginase, DNAse, Galactosidase, Superoxide dismutase), Antibidies, Vaccines & Adjuvants.
Future Therapeutics
An analysis of the next generation of bio-pharmaceuticals; with a specific emphasis on nucleic-acid (CRISPR, Gene Therapy, Antisense and Apatmer technologies) and cell-based (Stem Cells & Pharmabiotics) therapeutics.
Current Medical and Veterinary Applications
Detailed overview of the clinical conditions targeted by current (and future) BioPharmaceuticals.
Case study
A detailed profile of one of the major bio-pharmaceutical companies; focusing on a specific product, its production process and clinical indication.
Module Content & Assessment
Assessment Breakdown%
Coursework40.00%
End of Module Formal Examination60.00%

Assessments

Coursework
Assessment Type Other % of Total Mark 40
Timing Every Week Learning Outcomes 1,2,3,4,5
Assessment Description
Presentations together with a written report on a particular bio-pharmaceutical drug, the company which produces it, the production process and the disease which it targets.
End of Module Formal Examination
Assessment Type Formal Exam % of Total Mark 60
Timing End-of-Semester Learning Outcomes 1,2,3,4,5
Assessment Description
End-of-Semester Final Examination
Reassessment Requirement
Repeat examination
Reassessment of this module will consist of a repeat examination. It is possible that there will also be a requirement to be reassessed in a coursework element.

The University reserves the right to alter the nature and timings of assessment

 

Module Workload

Workload: Full Time
Workload Type Contact Type Workload Description Frequency Average Weekly Learner Workload Hours
Lecture Contact Class based instruction Every Week 2.00 2
Lecturer-Supervised Learning (Contact) Contact Case Study Every Week 1.00 1
Independent & Directed Learning (Non-contact) Non Contact Self directed learning Every Week 4.00 4
Total Hours 7.00
Total Weekly Learner Workload 7.00
Total Weekly Contact Hours 3.00
This module has no Part Time workload.
 
Module Resources
Recommended Book Resources
  • Sauna, Zuben E., Kimchi-Sarfaty, Chava (Eds.). (2017), Protein Therapeutics, [ISBN: 978-3-319-418].
This module does not have any article/paper resources
This module does not have any other resources
 
Module Delivered in
Programme Code Programme Semester Delivery
CR_SPHBI_8 Bachelor of Science (Honours) in Pharmaceutical Biotechnology 8 Mandatory